Endologix has announced that Vaseem Mahboob, chief financial officer (CFO), will be departing the company effective 1 July 2020 to become CFO of a private global healthcare company. Cindy Pinto, vice president, Financial Planning & Analysis, will assume the role of interim CFO in addition to her current responsibilities, and Endologix has initiated a search process for a permanent successor that will include both internal and external candidates.
John Onopchenko, CEO of Endologix, comments: “During his nearly five years at Endologix, Vaseem made immeasurable contributions as a key member of our executive team. His strong commitment to growing the Company was instrumental in driving our strategic plan. On behalf of the Board of Directors and the entire Endologix team, I thank Vaseem for his trusted partnership and his role in advancing the Endologix mission, and I wish him well in his new endeavour. Additionally, Cindy has been an integral part of the Finance team for nearly six years, and I am confident she will successfully lead the organisation through this transition.”
Vaseem Mahboob comments: “I am immensely proud of what the team has accomplished at Endologix, and it has been an honour to work for a company that is making such a profound difference in the lives of endovascular aneurysm repair (EVAR) patients. I know John and this team will carry on this mission, and I wish them all the best.”